Elastomeric Infusion Pumps Market – Insights
Elastomeric infusion pumps, also known as disposable balloon pumps, are used to administer IV drugs such as local anesthetics, antibiotics, and anti-neoplastics. These non-electronic, non-gravity driven devices are used in single infusions. Elastomeric infusion pumps contain a stretchable balloon reservoir that is filled with a drug and pressure from the elastic walls drives fluid delivery with relatively consistent pressure until it reaches near the end of the infusion.
The global elastomeric infusion pumps market is estimated to account for US$ 1,595.0 Mn in terms of value by the end of 2027
Global Elastomeric Infusion Pumps Market: Drivers
Post-operative pain in surgeries such as total knee replacement and total hip replacement is usually treated by infusion of analgesics through disposable infusion pumps. Therefore, increasing number of orthopedic procedures and surgeries is expected to boost growth of the global elastomeric infusion pumps market over the forecast period. For instance, The 2018 Annual Report of American Academy of Orthopedic Surgeons, over 1 million patients and over 1.4 million hip and knee arthroplasty procedures were entered into the American Joint Replacement Registry.
Moreover, elastomeric infusion pumps are cheaper and have fewer adverse effects compared to electronic pumps, which increases their adoption in ambulatory chemotherapy infusion centers. Moreover, as elastomeric infusion pumps do not require electricity to operate, the risk for free flow of medication to patients is eliminated. Such advantages of elastomeric infusion pumps over their electric counterparts is also expected to boost growth of the market.
North America region held dominant position in the global elastomeric infusion pumps market in 2018, accounting for 33.0% share in terms of value, followed by Asia Pacific.
Global Elastomeric Infusion Pumps Market: Restraints
The costs of elastomeric infusion pumps keeps fluctuating depending on the type of the pumps. For instance, the cost of pumps administering antibiotics is significantly low, whereas the cost of pumps administering pain management drugs is relatively high and ranges between US$ 160 and US$ 450. Such scenario is expected to hinder growth of the global elastomeric infusion pumps market over the forecast period.
Moreover, stringent regulations regarding the use of plastics in elastomeric infusion pumps is also expected to hamper the market growth. For instance, the European Commission and the U.S. FDA published a safety assessments of medical devices containing Di (2-ethylhexyl) phthalate (DEHP) and plasticized polyvinylchloride (PVC) in parts of elastomeric infusion pumps. Therefore, manufacturers need to focus on for proper safety labeling of products to avoid severe side effects, especially in neonatal patient population.
Global Elastomeric Infusion Pumps Market: Opportunities
Elastomeric infusion pumps can be used in portable regional anesthesia. Several studies have also demonstrated that the use of elastomeric infusion device following shoulder surgery allows safe and early discharge of patients with decreased need for parenteral opiate analgesia. Moreover, use of elastomeric infusion pumps in portable regional anesthesia is increasing in ambulatory care centers, dental care units, and cancer care centers the U.S., which is expected to offer lucrative growth opportunities for market players.
Moreover, increasing adoption of elastomeric infusion pumps in administration of chemotherapy drugs at ambulatory care centers and home care setting is also expected to offer significant growth opportunities for market players. Use of elastomeric infusion pumps aid in reducing wastage of chemotherapy drugs, which further helps in reducing cost of the treatment.
Global Continuous Rate Elastomeric Pumps elastomeric infusion pumps segment was valued at US$ 515.1 Mn market in 2018 and is forecast to reach a value of US$ 1,095.1 Mn by 2027 at a CAGR of 8.8% between 2019 and 2027
Global Elastomeric Infusion Pumps Market: Market Trends
Increasing R&D for novel applications of elastomeric infusion pumps is a recent trend in the market. For instance, in September 2018, researchers from University Hospital of Lausanne, Switzerland, assessed the use of two submuscular catheters connected to two elastomeric pumps in postoperative continuous wound infiltration of levobupivacaine.
Moreover, increasing use of elastomeric infusion pumps outpatient parenteral antimicrobial therapy is also expected to boost growth of the market. For instance, in 2018, a study in Journal of Antimicrobial Chemotherapy concluded that continuous infusions of flucloxacillin, cefepime, vancomycin and piperacillin/tazobactam using elastomeric infusion pumps is effective in outpatient parenteral antimicrobial therapy.
Global Elastomeric Infusion Pumps Market: Regulations
Key players in the market need to focus on effects of temperature, fill volume, and diluent on flow rates in elastomeric infusion pumps. Proper labelling of flow rates and monitoring of models as per desired infusion time is also important while production of the infusion pumps.
Global Elastomeric Infusion Pumps Market: Competitive Landscape
Key players in the market are focused on integrating elastomeric infusion pumps with other digital technologies. For instance, in April 2017, B. Braun Medical Inc. integrated its Easypump ST/LT Elastomeric Infusion Pump System with an innovative app that offers educational content to clinicians and patients on the safe use and features of the Easypump for short- and long-term home infusion therapy.
Major players operating in the global elastomeric infusion pumps market include, B. Braun Melsungen AG, Fresenius Kabi, Leventon, S.A.U, Ambu A/S, Baxter International Inc., Halyard Health, and Nipro Corporation.